Effect of early dexamethasone on outcomes of COVID-19: A quasi-experimental study using propensity score matching
CONCLUSION: An early start of dexamethasone (within 7 days after the onset of symptoms) could be harmful to hospitalized patients with COVID-19.PMID:38402071 | DOI:10.1016/j.jmii.2024.02.002
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Wang-Da Liu Jann-Tay Wang Ming-Chieh Shih Kai-Hsiang Chen Szu-Ting Huang Chun-Fu Huang Tien-Hao Chang Ming-Jui Tsai Po-Hsien Kuo Yi-Chen Yeh Wan-Chen Tsai Mei-Yan Pan Guei-Chi Li Yi-Jie Chen Kuan-Yin Lin Yu-Shan Huang Aristine Cheng Pao-Yu Chen Sung-Ching Source Type: research
More News: Allergy & Immunology | COVID-19 | Dexamethasone | Microbiology | SARS | Study | Taiwan Health